Basel, Switzerland

Shinji Hatakeyama

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 7.8

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2015-2022

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Innovations and Contributions of Shinji Hatakeyama

Introduction

Shinji Hatakeyama is a prominent inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for cancer cachexia. With a total of six patents to his name, Hatakeyama's work has the potential to impact the lives of many patients undergoing cancer treatment.

Latest Patents

One of Hatakeyama's latest patents focuses on the uses of myostatin antagonists, specifically for the treatment of cancer cachexia. This invention highlights the benefits of the myostatin antagonist bimagrumab in reducing body weight loss associated with cancer cachexia and chemotherapeutic treatments. Additionally, it explores combinations of myostatin antagonists and mTOR inhibitors for treating cancer cachexia and age-related conditions. Another notable patent involves a benzothiazolone compound, which includes a method for manufacturing the compound and its therapeutic uses, along with combinations of pharmacologically active agents and pharmaceutical compositions.

Career Highlights

Shinji Hatakeyama is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development in pharmaceuticals.

Collaborations

Some of Hatakeyama's notable coworkers include Robin Alec Fairhurst and Arnaud Grandeury. Their collaborative efforts have further advanced the research and development of innovative treatments in the pharmaceutical industry.

Conclusion

Shinji Hatakeyama's contributions to the field of pharmaceuticals, particularly in the treatment of cancer cachexia, demonstrate his commitment to innovation and improving patient outcomes. His patents reflect a deep understanding of the complexities of cancer treatment and the potential for new therapeutic approaches.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…